Dose-Escalation Safety and Pharmacokinetic Study of ATX-101

Status:
Completed

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

The purpose of this research is to evaluate the safety and pharmacokinetic profile of single doses of ATX-101

Phase 1

Kythera Biopharmaceuticals